Showing 231-240 of 3101 results for "".
Monoclonal Antibody Therapy in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/monoclonal-antibody-therapy-in-multiple-sclerosi/30209/Finding the forest among the trees with an update on the safety, efficacy, and mechanisms of monoclonal antibodies.- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31419/Idiopathic Hypersomnia: A Distinct Clinical Entity Beyond NarcolepsyIn a case highlighted by Robert Fayle, MD, a 31-year-old woman with a longstanding history of excessive daytime sleepiness (EDS) since age 14 presents a compelling example of idiopathic central nervous system hypersomnia. Unlike nar
Practice Management: New Solutions for Old Problems
https://practicalneurology.com/diseases-diagnoses/neuromuscular/1109_03-php/30872/Big changes to Medicare are coming. Here's a look at how you and your practice can prepare for success in the new decade.The Benefits of Collaborative Care
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-benefits-of-collaborative-care/30252/Parkinson's Pipeline: Promise in Research and Treatment
https://practicalneurology.com/diseases-diagnoses/movement-disorders/parkinsons-pipeline-promise-in-research-and-treatment/30506/At the Michael J. Fox Foundation's Parkinson's Disease Therapeutics Conference, experts revealed encouraging new directions in treating and understanding PD.NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/nmosd-part-3-overview-of-treatment-including-goals-triggers-and-considerations-for-switching-therapies/30089/In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podPD GENEration and Barriers to Parkinson Diagnosis - Part 1
https://practicalneurology.com/diseases-diagnoses/movement-disorders/pd-generation-and-barriers-to-parkinson-diagnosis-part-1/30095/Chantale Branson, MD, Associate Professor of Neurology at Morehouse School of Medicine, Atlanta, GA, is a researcher working on the pivotal PD GENEration study, which aims to improve treatment options through the identification of clinically relevant genes linked to Parkinson disease. In this episodNMOSD Part 2 - The importance and tools for monitoring NMOSD, and signs, symptoms and evaluation of disease activity
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/nmosd-part-2-the-importance-and-tools-for-monitoring-nmosd-and-signs-symptoms-and-evaluation-of-disease-activity/30088/In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podThe Power of Movement for Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/the-power-of-movement-for-parkinson-disease/57106/Nina Mosier, MD, an Internal Medicine physician specializing in Geriatric Medicine in Austin, TX, shares the journey of her father after his diagnosis with Parkinson disease. She also discusses the importance of movement in these patients and describes “Power for Parkinson’s”, a nonprofit organizatiSurviving Stroke: 2 Surgeons Experience with Recovery
https://practicalneurology.com/diseases-diagnoses/stroke/surviving-stroke-2-surgeons-experience-with-recovery/30087/Siva Murugappan, MD, General Surgeon, Chatham-Kent Health Alliance, Ontario, Canada, shares his own experiences as a patient recovering from an ischemic stroke. He is joined by his wife and caregiver, Dr. Prema Samy, Otolaryngologist, Chatham-Kent Health Alliance, Ontario, Canada, as they both discu